HBV Reactivation in Immunocompromised Patients (REANT STUDY)
NCT07529171
·
clinicaltrials.gov ↗
RECRUITING
Status
490
Enrollment
OTHER
Sponsor class
Conditions
HBV
Interventions
DRUG:
Antiviral
Sponsor
Yaşar Bayındır, MD
Collaborators
[object Object]